Berenberg Bank analyst Luisa Hector maintained a Buy rating on Merck & Company (MRK – Research Report) yesterday and set a price ...

TIME convened the first-ever TIME100 Health Leadership Forum to bring together individuals driving innovation and creating ...

Global Thrombocytopenia Treatment IndustryThe global Thrombocytopenia Treatment Market is projected to experience significant ...

Zacks Research lowered their Q3 2024 earnings estimates for Merck & Co., Inc. in a report issued on Monday, October 21st.

The MSA therapeutics market is valued at US$ 137.3 million in 2023. The market is projected to expand at a 4.4% CAGR from ...

In recent trading, Merck & Co Inc (MRK) stock price has shown some volatility, fluctuating -3.05% over the last five trades and -9.24% over the past 30 trades. This represents a notable shift from ...

Empowering young women with the confidence to excel in their education is key to inspiring the next generation' ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Utilization in fine chemical synthesis processes for the production of specialty chemicals and intermediates drives <a ...

Report with the AI impact on market trends- The global sexually transmitted disease (STD) testing market size is estimated to ...

On Saturday, Gilead Sciences, Inc. (NASDAQ:GILD) and Merck & Co. Inc. (NYSE:MRK) revealed new results from a Phase 2 clinical ...